Intestinal Research

IBD
Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis: Hyuk Yoon; Intest Res. 2019;17(3):283-284. Published online July 25, 2019; DOI: https://doi.org/10.5217/ir.2019.00070; Full text PubReader ePub Crossref - TDM PDF

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia: Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chian Lim, Wai Keung Leung, Raja Affendi Raja Ali, Deng Chyang Wu, Evan Ong, Nazri Mustaffa, Julajak Limsrivilai, Tadakazu Hisamatsu, Suk Kyun Yang, Qin Ouyang, Richard Geary, Janaka H De Silva, Rungsun Rerknimitr, Marcellus Simadibrata, Murdani Abdullah, Rupert WL Leong, the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn’s and Colitis; Intest Res. 2019;17(3):285-310. Published online May 31, 2019; DOI: https://doi.org/10.5217/ir.2019.00026
Cited By 65; Full text PubReader ePub Crossref - TDM PDF

Stem cell-based therapy for inflammatory bowel disease: Hiromichi Shimizu, Kohei Suzuki, Mamoru Watanabe, Ryuichi Okamoto; Intest Res. 2019;17(3):311-316. Published online July 25, 2019; DOI: https://doi.org/10.5217/ir.2019.00043
Cited By 15; Full text PubReader ePub Crossref - TDM PDF

Tumor
Prevalence and risk factors of colorectal cancer in Asia: Martin CS Wong, Hanyue Ding, Jingxuan Wang, Paul SF Chan, Junjie Huang; Intest Res. 2019;17(3):317-329. Published online May 20, 2019; DOI: https://doi.org/10.5217/ir.2019.00021
Cited By 113; Full text PubReader ePub Crossref - TDM PDF

Inflammatory bowel diseases
Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East: Masoud M Malekzadeh, Alireza Sima, Sudabeh Alatab, Anahita Sadeghi, Nasser Ebrahimi Daryani, Payman Adibi, Iradj Maleki, Hassan Vossoughinia, Hafez Fakheri, Abbas Yazdanbod, Seyed Alireza Taghavi, Rahim Aghazadeh, Mohammad Hassan Somi, Kazem Zendedel, Homayoon Vahedi, Reza Malekzadeh; Intest Res. 2019;17(3):330-339. Published online April 24, 2019; DOI: https://doi.org/10.5217/ir.2018.00157
Cited By 11; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Ustekinumab is effective in biological refractory Crohn’s disease patients–regardless of approval study selection criteria: Sadik Saman, Martin Goetz, Judith Wendler, Nisar P. Malek, Jan Wehkamp, Thomas Klag; Intest Res. 2019;17(3):340-348. Published online May 31, 2019; DOI: https://doi.org/10.5217/ir.2019.00012
Cited By 17; Full text PubReader ePub Crossref - TDM PDF

Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study: Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park; Intest Res. 2019;17(3):349-356. Published online February 8, 2019; DOI: https://doi.org/10.5217/ir.2018.00064
Cited By 4; Full text PubReader ePub Crossref - TDM PDF

Risk of surgery in patients with stricturing type of Crohn’s disease at the initial diagnosis: a single center experience: Yuji Maehata, Yutaka Nagata, Tomohiko Moriyama, Yuichi Matsuno, Atsushi Hirano, Junji Umeno, Takehiro Torisu, Tatsuya Manabe, Takanari Kitazono, Motohiro Esaki; Intest Res. 2019;17(3):357-364. Published online February 21, 2019; DOI: https://doi.org/10.5217/ir.2018.00107
Cited By 7; Full text PubReader ePub Crossref - TDM PDF

Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis: Alissa Walsh, Lawrence Matini, Christopher Hinds, Vanashree Sexton, Oliver Brain, Satish Keshav, John Geddes, Guy Goodwin, Gary Collins, Simon Travis, Michele Peters; Intest Res. 2019;17(3):365-374. Published online May 31, 2019; DOI: https://doi.org/10.5217/ir.2018.00173
Cited By 9; Full text PubReader ePub Crossref - TDM PDF

Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study: Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki; Intest Res. 2019;17(3):375-386. Published online February 12, 2019; DOI: https://doi.org/10.5217/ir.2018.00141
Cited By 11; Full text PubReader ePub Crossref - TDM PDF

Quantitative histology-based classification system for assessment of the intestinal mucosal histological changes in patients with celiac disease: Prasenjit Das, Gaurav PS Gahlot, Alka Singh, Vandana Baloda, Ramakant Rawat, Anil K Verma, Gaurav Khanna, Maitrayee Roy, Archana George, Ashok Singh, Aasma Nalwa, Prashant Ramteke, Rajni Yadav, Vineet Ahuja, Vishnubhatla Sreenivas, Siddhartha Datta Gupta, Govind K Makharia; Intest Res. 2019;17(3):387-397. Published online April 22, 2019; DOI: https://doi.org/10.5217/ir.2018.00167
Cited By 12; Full text PubReader ePub Crossref - TDM PDF

Colorectal tumors
Endoscopic features of gastrointestinal stromal tumor in the small intestine: Yutaro Ihara, Takehiro Torisu, Tomohiko Moriyama, Junji Umeno, Atsushi Hirano, Yasuharu Okamoto, Yoshifumi Hori, Hidetaka Yamamoto, Takanari Kitazono, Motohiro Esaki; Intest Res. 2019;17(3):398-403. Published online July 25, 2019; DOI: https://doi.org/10.5217/ir.2018.00161
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Association of visceral adiposity and insulin resistance with colorectal adenoma and colorectal cancer: In Sub Jung, Cheol Min Shin, Sung Jae Park, Young Soo Park, Hyuk Yoon, Hyun Jin Jo, Nayoung Kim, Dong Ho Lee; Intest Res. 2019;17(3):404-412. Published online November 12, 2018; DOI: https://doi.org/10.5217/ir.2018.00072
Cited By 10; Full text PubReader ePub Crossref - TDM PDF

Endoscopy
Clinical comparison of low-volume agents (oral sulfate solution and sodium picosulfate with magnesium citrate) for bowel preparation: the EASE study: Jeeyeon Kim, Hyun Gun Kim, Kyeong Ok Kim, Hyung Wook Kim, Jongha Park, Jeong-Sik Byeon, Sung-Wook Hwang, Hyun Deok Shin, Jeong Eun Shin, Hyo-Joon Yang, Hyun Seok Lee, Yunho Jung, Young-Seok Cho, Young Eun Joo, Dae-Seong Myung, Kyu Chan Huh, Eu Mi Ahn; Intest Res. 2019;17(3):413-418. Published online April 8, 2019; DOI: https://doi.org/10.5217/ir.2018.00156
Cited By 8; Full text PubReader ePub Crossref - TDM PDF

Functional bowel disorders
Is stool frequency associated with the richness and community composition of gut microbiota?: Hye Jung Kwon, Jong Hyun Lim, Dongmin Kang, Sanghyun Lim, Seun Ja Park, Jae Hyun Kim; Intest Res. 2019;17(3):419-426. Published online February 7, 2019; DOI: https://doi.org/10.5217/ir.2018.00149
Cited By 19; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Evaluation of symptoms and symptom combinations in histamine intolerance: Wolfgang J. Schnedl, Sonja Lackner, Dietmar Enko, Michael Schenk, Sandra J. Holasek, Harald Mangge; Intest Res. 2019;17(3):427-433. Published online March 7, 2019; DOI: https://doi.org/10.5217/ir.2018.00152
Cited By 29; Full text PubReader ePub Crossref - TDM PDF

Miscellaneous
Fecal microbiota transplant via colonoscopy may be preferred due to intraprocedure findings: Janice M. Cho, Laura Pestana, Ryan Pardi, Darrell S. Pardi, Sahil Khanna; Intest Res. 2019;17(3):434-437. Published online May 31, 2019; DOI: https://doi.org/10.5217/ir.2019.00056
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

IBD
A pulmonary nodule in a patient with Crohn’s disease: Akira Hokama, Shusaku Haranaga, Takanobu Sasaki, Hirofumi Matsumoto, Tetsuya Ohira, Atsushi Iraha, Tetsu Kinjo, Saifun Nahar, Jiro Fujita; Intest Res. 2019;17(3):438-439. Published online February 11, 2019; DOI: https://doi.org/10.5217/ir.2019.00010; Full text PubReader ePub Crossref - TDM PDF

Previous issues